Thome covers the Healthcare sector, focusing on stocks such as Alkermes, Jazz Pharmaceuticals ... AnaptysBio (ANAB) Company Description: AnaptysBio, Inc. is a clinical stage biotechnology company, ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on PepGen Inc. (PEPG – Research Report) on November 8 and set a price target ...

Alkermes plc announced today that management will participate at two upcoming investor conferences. Stifel Healthcare ConferenceDate/Time: Monday, Nov. 18, 2024 at 8:35 a.m. ET (1:35 p.m. GMT) ...

About Celldex Therapeutics, Inc. and Alkermes plc Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of ...

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Velocity One, a newly formed aerospace manufacturing holding company, announced the acquisition of Emcore Corp. for $31.4 ...

A New England-based company that specializes in enhancing athletes' grip struck a deal with two sharks on "Shark Tank." ...

This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 11.57%. This prediction currently runs until 25.10.25. The prediction end date can be ...